UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Genetic loci associated with Alzheimer's disease and cerebrospinal fluid biomarkers in a Finnish case-control cohort

PloS one, 2013-04, Vol.8 (4), p.e59676-e59676

2013

Volltextzugriff (PDF)

Relationship between genetic risk factors and markers for Alzheimer's disease pathology

Biomarkers in medicine, 2012-08, Vol.6 (4), p.477-495

2012

Volltextzugriff (PDF)

Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis

Journal of neurology, neurosurgery and psychiatry, 2011-10, Vol.82 (10), p.1149-1156

2011

Volltextzugriff (PDF)

APOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a primary care setting

Cochrane library, 2014-01

2014

Volltextzugriff (PDF)

APOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a primary care setting

Cochrane database of systematic reviews, 2018-08, Vol.2018 (8)

2018

Volltextzugriff (PDF)

APOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a community setting

Cochrane database of systematic reviews, 2018-08, Vol.2018 (8)

2018

Volltextzugriff (PDF)

APOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a secondary care setting

Cochrane database of systematic reviews, 2018-08, Vol.2018 (8)

2018

Volltextzugriff (PDF)

Meta-analysis of CSF biomarkers as predictor for conversion from mild cognitive impairment to Alzheimer's disease

Alzheimer's & dementia, 2010-07, Vol.6 (4), p.S521-S522

2010

Volltextzugriff (PDF)

The association between APOE ε4 and Alzheimer-type dementia among memory clinic patients is confined to those with a higher education. The DESCRIPA Study

Journal of Alzheimer's disease, 2013, Vol.35 (2), p.241-246

2013

Volltextzugriff (PDF)

How well does ApoE-ϵ4 predict Alzheimer's disease in persons with mild cognitive impairment?

Alzheimer's & dementia, 2009-07, Vol.5 (4), p.P288-P288

2009

Volltextzugriff (PDF)

APOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a community setting

Cochrane library, 2014-01

2014

Volltextzugriff (PDF)

APOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a secondary care setting

Cochrane library, 2014-01

2014

Volltextzugriff (PDF)

Predictive value of APOE- 4 allele for progression from MCI to AD-type dementia: a meta-analysis

Journal of neurology, neurosurgery and psychiatry, 2011-10, Vol.82 (10), p.1149-1156

2011

Volltextzugriff (PDF)

Relationship between genetic risk factors and markers for Alzheimer s disease pathology

Biomarkers in medicine, 2012-08, Vol.6 (4), p.477-495

2012

Volltextzugriff (PDF)

Predictive value of APOE- epsilon 4 allele for progression from MCI to AD-type dementia: a meta-analysis

Journal of neurology, neurosurgery and psychiatry, 2011-01, Vol.82 (10), p.1149-1156

2011

Volltextzugriff (PDF)

P3‐239: Meta‐analysis of CSF biomarkers as predictor for conversion from mild cognitive impairment to Alzheimer's disease

Alzheimer's & dementia, 2010-07, Vol.6 (4S_Part_17), p.S521-S522

2010

Volltextzugriff (PDF)

P2‐090: How well does ApoE‐ϵ4 predict Alzheimer's disease in persons with mild cognitive impairment?

Alzheimer's & dementia, 2009-07, Vol.5 (4S_Part_9), p.P288-P288

2009

Volltextzugriff (PDF)

Genetic Loci Associated with Alzheimers Disease and Cerebrospinal Fluid Biomarkers in a Finnish Case-Control Cohort. e59676

PloS one, 2013-04, Vol.8 (4)

2013

Volltextzugriff (PDF)

Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition

Journal of Alzheimer's disease, 2017-01, Vol.60 (3), p.1025-1034

2017

Volltextzugriff (PDF)

P1–211: Effects of MS4A variants on cerebrospinal fluid beta‐amyloid 1–42

Alzheimer's & dementia, 2013-07, Vol.9 (4S_Part_6), p.P229-P230

2013

Volltextzugriff (PDF)

Effects of MS4A variants on cerebrospinal fluid beta-amyloid 1-42

Alzheimer's & dementia, 2013-07, Vol.9 (4), p.P229-P230

2013

Volltextzugriff (PDF)

O3‐05‐03: Relation between Alzheimer's genetic risk factors and long‐term memory decline in nondemented subjects with cognitive impairments

Alzheimer's & dementia, 2012-07, Vol.8 (4S_Part_12), p.P437-P437

2012

Volltextzugriff (PDF)

Relation between Alzheimer's genetic risk factors and long-term memory decline in nondemented subjects with cognitive impairments

Alzheimer's & dementia, 2012-07, Vol.8 (4), p.P437-P437

2012

Volltextzugriff (PDF)

Genetic Risk Factors for AD Biomarkers

Alzheimer's & dementia, 2011-07, Vol.7 (4), p.S184-S184

2011

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(36)

Sprache

Englisch
(36)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Neurology
(14)
Alzheimer's Disease
(6)
Humans
(6)
Aged
(5)
Alzheimer Disease - Genetics
(5)
Female
(5)
Male
(5)
Science & Technology
(5)
Dementia
(4)
Life Sciences & Biomedicine
(4)
Middle Aged
(4)
Studies
(4)
Amyloid
(3)
Apolipoprotein E4 - Genetics
(3)
Cognitive Ability
(3)
Genetics
(3)
Medicin Och Hälsovetenskap
(3)
Medicine General & Introductory Medical Sciences
(3)
Memory
(3)
Mild Cognitive Impairment
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genetic loci associated with Alzheimer's disease and cerebrospinal fluid biomarkers in a Finnish case-control cohort

Relationship between genetic risk factors and markers for Alzheimer's disease pathology

Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis

APOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a primary care setting

APOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a primary care setting

APOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a community setting

APOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a secondary care setting

DNMT3A moderates cognitive decline in subjects with mild cognitive impairment: replicated evidence from two mild cognitive impairment cohorts

Meta-analysis of CSF biomarkers as predictor for conversion from mild cognitive impairment to Alzheimer's disease

The association between APOE ε4 and Alzheimer-type dementia among memory clinic patients is confined to those with a higher education. The DESCRIPA Study

How well does ApoE-ϵ4 predict Alzheimer's disease in persons with mild cognitive impairment?

APOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a community setting

APOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a secondary care setting

Predictive value of APOE- 4 allele for progression from MCI to AD-type dementia: a meta-analysis

Relationship between genetic risk factors and markers for Alzheimer s disease pathology

Predictive value of APOE- epsilon 4 allele for progression from MCI to AD-type dementia: a meta-analysis

P3‐239: Meta‐analysis of CSF biomarkers as predictor for conversion from mild cognitive impairment to Alzheimer's disease

P2‐090: How well does ApoE‐ϵ4 predict Alzheimer's disease in persons with mild cognitive impairment?

Genetic Loci Associated with Alzheimers Disease and Cerebrospinal Fluid Biomarkers in a Finnish Case-Control Cohort. e59676

Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition

P1–211: Effects of MS4A variants on cerebrospinal fluid beta‐amyloid 1–42

Effects of MS4A variants on cerebrospinal fluid beta-amyloid 1-42

O3‐05‐03: Relation between Alzheimer's genetic risk factors and long‐term memory decline in nondemented subjects with cognitive impairments

Relation between Alzheimer's genetic risk factors and long-term memory decline in nondemented subjects with cognitive impairments

Genetic Risk Factors for AD Biomarkers

Suchergebnisse filtern